PTC Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	672.62	779.71	594	279.83	189.72	208.81
Short-Term Investments	1,035	373.75	288.81	130.87	583.66	894.84
Cash & Short-Term Investments	1,707	1,153	882.81	410.71	773.38	1,104
Cash Growth	66.83%	30.66%	114.95%	-46.89%	-29.93%	60.75%
Receivables	203.07	158.55	261.02	155.61	110.46	69.93
Inventory	52.69	23.19	30.58	21.81	15.86	18.7
Prepaid Expenses	44.73	22.93	41.62	105.66	54.68	39.47
Other Current Assets	-	7.4	2.6	-	-	-
Total Current Assets	2,008	1,366	1,219	693.79	954.37	1,232
Property, Plant & Equipment	137.65	117.66	178.99	175.02	130.01	118.24
Long-Term Investments	-	-	-	-	21	29.3
Goodwill	82.34	82.34	82.34	82.34	82.34	82.34
Other Intangible Assets	396.47	118.79	379.5	705.89	724.84	715.33
Other Long-Term Assets	19.44	20.7	36.25	48.58	25.5	31.32
Total Assets	2,644	1,705	1,896	1,706	1,938	2,208
Accounts Payable	36.62	17.27	6.05	27.27	23.03	18.67
Accrued Expenses	246.23	261.62	366.26	276.33	251.83	209.83
Current Portion of Long-Term Debt	546.93	257.82	194.31	72.15	208.83	21.02
Current Portion of Leases	14.49	13.36	16	12.37	10.27	8.74
Current Income Taxes Payable	2.93	4.7	-	4.71	1.29	4.32
Current Unearned Revenue	1.69	5.51	0.8	1.35	-	4.15
Other Current Liabilities	17.37	20.7	19.67	12.05	14.1	10.61
Total Current Liabilities	866.25	580.98	603.1	406.24	509.35	277.33
Long-Term Debt	1,821	2,109	1,904	1,257	956.59	967.88
Long-Term Leases	109.32	90.52	114.81	119.54	93.67	102.55
Long-Term Deferred Tax Liabilities	-	-	55.91	102.83	137.11	136.74
Other Long-Term Liabilities	2.58	22.23	36.44	166.64	239.9	241.79
Total Liabilities	2,799	2,803	2,714	2,053	1,937	1,726
Common Stock	0.08	0.08	0.08	0.07	0.07	0.07
Additional Paid-In Capital	2,667	2,575	2,466	2,305	2,124	2,172
Retained Earnings	-2,829	-3,647	-3,284	-2,657	-2,098	-1,629
Comprehensive Income & Other	5.93	-25.89	-1.29	4.8	-24.28	-60.96
Shareholders' Equity	-155.76	-1,098	-818.56	-347.09	1.44	481.98
Total Liabilities & Equity	2,644	1,705	1,896	1,706	1,938	2,208
Total Debt	2,492	2,471	2,229	1,462	1,269	1,100
Net Cash (Debt)	-784.74	-1,318	-1,346	-1,051	-495.99	3.45
Net Cash Growth	-	-	-	-	-	-99.04%
Net Cash Per Share	-9.29	-17.15	-17.99	-14.65	-7.04	0.05
Filing Date Shares Outstanding	80.29	78.87	76.61	73.82	71.36	70.32
Total Common Shares Outstanding	79.93	77.7	75.71	73.1	70.83	69.72
Working Capital	1,142	784.55	615.53	287.55	445.02	954.41
Book Value Per Share	-1.95	-14.13	-10.81	-4.75	0.02	6.91
Tangible Book Value	-634.57	-1,299	-1,280	-1,135	-805.74	-315.69
Tangible Book Value Per Share	-7.94	-16.72	-16.91	-15.53	-11.38	-4.53
Machinery	-	59.76	84.19	66.64	50.8	38.75
Construction In Progress	-	3.03	24.01	14.35	9.02	5.08
Leasehold Improvements	-	31.53	30.17	28.97	19.94	8.07

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q